Newsroom

BOSTON--(BUSINESS WIRE)--Loomis, Sayles & Company, gestionnaire d’investissement mondial avec près de 390 milliards de dollars d’actifs sous gestion au 31 mars 2025, a annoncé que Lynne Royer, coresponsable et gestionnaire de portefeuille de la Disciplined Alpha Team, prendra sa retraite fin 2025 après une carrière d’investissement remarquable s’étendant sur quatre décennies. Brad Stevens, gestionnaire de portefeuille de longue date, a en outre été promu coresponsable de l’équipe aux côtés...

BOSTON--(BUSINESS WIRE)--Loomis, Sayles & Company, gestore globale di investimenti con quasi 390 miliardi di dollari USA di asset in gestione al 31 marzo 2025, ha annunciato il ritiro di Lynne Royer, co-responsabile e gestore del portafoglio del Disciplined Alpha Team, alla fine del 2025, dopo un'eccezionale carriera negli investimenti durata quarant'anni. Brad Stevens, CFA, storico gestore del portafoglio, è stato inoltre promosso a co-responsabile del team congiuntamente a Lynne e Seth Ti...

BOSTON--(BUSINESS WIRE)--Loomis, Sayles & Company, de wereldwijde vermogensbeheerder met bijna $ 390 miljard aan beheerd vermogen per 31 maart 2025, heeft aangekondigd dat Lynne Royer, co-hoofd en portfoliobeheerder van het Disciplined Alpha Team, eind 2025 met pensioen gaat na een opmerkelijke beleggingscarrière van vier decennia. Daarnaast is Brad Stevens, CFA, de ervaren portfoliobeheerder, gepromoveerd tot co-hoofd van het team, naast Lynne en Seth Timen, die het team sinds 2021 samen h...

川崎--(BUSINESS WIRE)--（ビジネスワイヤ） -- 東芝デバイス＆ストレージ株式会社は、スイッチング電源や太陽光発電用インバーターなどの産業用機器向けに、当社最新[注1]の第３世代シリコンカーバイド (SiC) MOSFETチップを小型DFN8×8パッケージに搭載した、650V耐圧の４製品「TW031V65C」、「TW054V65C」、「TW092V65C」、「TW123V65C」を製品化しました。本日から量産出荷を開始します。 新製品は、第３世代SiC MOSFETで当社初の小型面実装パッケージのDFN8×8を採用しています。従来のリード挿入型パッケージのTO-247、TO-247-4L(X)パッケージに比べ体積が90%以上削減されており、機器の電力密度の向上に貢献します。 また、面実装によりリード挿入型より寄生インピーダンス[注2]成分が小さくなり、スイッチング損失を低減します。さらに、4端子タイプ[注３]であるため、ゲートドライブ用の信号ソース端子をケルビン接続することで、パッケージ内部にあるソースワイヤのインダクタンスによるスイッチングへの影響を小さくでき、高...

KAWASAKI, Japan--(BUSINESS WIRE)--Toshiba releases 650V 3rd generation SiC MOSFETs in DFN8x8 package. Four new devices boost efficiency and power density of industrial equipment....

LEHI, Utah--(BUSINESS WIRE)--Weave (NYSE: WEAV), a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses, today announced the successful closing of its previously announced acquisition of TrueLark. Truelark is an AI-powered receptionist and front-desk automation platform. The transaction marks a significant milestone in Weave’s strategy to lead the next evolution of AI in healthcare communications. Additionally, on May 16, 2025, W...

SEOUL, South Korea--(BUSINESS WIRE)--Funds managed by Hamilton Lane have invested through a secondary transaction in the IMM Infra 8th Private Equity Fund....

NEW YORK--(BUSINESS WIRE)--The BlackRock closed-end funds (the “Funds”) listed below announced today the expiration and preliminary results of each Fund’s tender offer (each, a “Tender Offer”) for up to 2.5% of its outstanding common shares (the “Shares”). Each Tender Offer commenced on April 16, 2025 and expired at 5:00 p.m. Eastern time on May 19, 2025. Based on preliminary information, the number of Shares properly tendered for each Fund and not withdrawn is noted in the table below. Fund Na...

HONG KONG--(BUSINESS WIRE)--Wolters Kluwer Financial & Corporate Compliance today announces that Shanghai Commercial Bank (SCB) has implemented a comprehensive regulatory reporting and risk management platform using its OneSumX solution suite. This marks a significant step in SCB’s Governance, Risk, and Compliance (GRC) initiative, creating a unified source of truth for Basel compliance, regulatory reporting, risk analysis, and stress testing. SCB is now compliant with the Basel III require...

SENDAI, Japan--(BUSINESS WIRE)--RevolKa Ltd. (RevolKa), a venture-backed biotech company providing a cutting-edge AI-driven protein engineering technology platform called aiProtein®, has raised 210 million JPY (US$1.4M) in Series A extension funding. This funding will advance RevolKa’s drug discovery programs for rare diseases (https://www.revolka.com/news/english/collab-en/a65) and support collaborative partnering efforts. This financing round was co-led by existing investors, D3 LLC (Tomoya N...